Literature DB >> 22537609

Oxaliplatin-induced hepatoportal sclerosis, portal hypertension, and variceal bleeding successfully treated with transjugular intrahepatic portosystemic shunt.

Taoreed O Lawal1, Alton B Farris, Bassel F El-Rayes, Ram M Subramanian, Hyun S Kim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22537609     DOI： 10.1016/j.clcc.2012.02.002

Source DB:  PubMed          Journal:  Clin Colorectal Cancer        ISSN： 1533-0028            Impact factor:   4.481


× No keyword cloud information.
  8 in total

1.  Esophagogastric varices were diagnosed in a non-cirrhotic liver case during long-term follow-up after oxaliplatin-based chemotherapy.

Authors:  Ryuta Shigefuku; Tsunamasa Watanabe; Takuro Mizukami; Kotaro Matsunaga; Nobuhiro Hattori; Takuya Ehira; Tatsuya Suzuki; Hiroyasu Nakano; Yoshinori Sato; Yasumasa Matsuo; Kazunari Nakahara; Hiroki Ikeda; Nobuyuki Matsumoto; Takashi Tsuda; Masafumi Katayama; Satoshi Koizumi; Chiaki Okuse; Michihiro Suzuki; Takehito Otsubo; Takako Eguchi Nakajima; Hiroshi Yasuda; Fumio Itoh
Journal:  Clin J Gastroenterol       Date:  2018-06-11

Review 2.  Diagnostic challenges in non-cirrhotic portal hypertension - porto sinusoidal vascular disease.

Authors:  Oana Nicoară-Farcău; Ioana Rusu; Horia Stefănescu; Marcel Tanțău; Radu Ion Badea; Bogdan Procopeț
Journal:  World J Gastroenterol       Date:  2020-06-14       Impact factor: 5.742

Review 3.  Porto-Sinusoidal Vascular Disease Associated to Oxaliplatin: An Entity to Think about It.

Authors:  Angela Puente; Jose Ignacio Fortea; Carmen Del Pozo; Patricia Huelin; Maria Luisa Cagigal; Marina Serrano; Joaquin Cabezas; Maria Teresa Arias Loste; Paula Iruzubieta; Antonio Cuadrado; Susana Llerena; Carlos Lopez; Emilio Fábrega; Javier Crespo
Journal:  Cells       Date:  2019-11-24       Impact factor: 6.600

Review 4.  Surgical intervention for portal hypertension caused by oxaliplatin-based chemotherapy: a case report and a review of literature regarding radiological and/or surgical interventions for oxaliplatin-associated portal hypertension.

Authors:  Daisuke Morioka; Yusuke Izumisawa; Kazuya Yamaguchi; Kei Sato; Satoshi Komiyama; Kazuya Nakagawa; Manabu Kakizoe; Takashi Murakami; Yoshiki Sato
Journal:  Clin J Gastroenterol       Date:  2020-06-26

5.  Prediction of esophagogastric varices associated with oxaliplatin administration.

Authors:  Yosuke Satta; Ryuta Shigefuku; Tsunamasa Watanabe; Takuro Mizukami; Takashi Tsuda; Tatsuya Suzuki; Takuya Ehira; Nobuhiro Hattori; Hirofumi Kiyokawa; Kazunari Nakahara; Hiroki Ikeda; Kotaro Matsunaga; Hideaki Takahashi; Nobuyuki Matsumoto; Chiaki Okuse; Michihiro Suzuki; Yu Sunakawa; Hiroshi Yasuda; Fumio Itoh
Journal:  JGH Open       Date:  2021-11-02

6.  Arterioportal shunt incidental to treatment with oxaliplatin that mimics recurrent gastric cancer.

Authors:  Hong-Beum Kim; Sang-Gon Park
Journal:  World J Gastroenterol       Date:  2017-09-07       Impact factor: 5.742

7.  Direct Intrahepatic Portocaval Shunt for Sinusoidal Obstruction Syndrome Associated with Hepatotoxicity of Pyrrolizidine Alkaloids.

Authors:  Shihua Luo; Jianguo Chu; He Huang; Kechun Yao
Journal:  Biomed Res Int       Date:  2018-06-13       Impact factor: 3.411

8.  A Rare Cause of Gastric Variceal Bleeding.

Authors:  Yesenia Ramos; Dorina Gui; Eric Chak
Journal:  Case Rep Gastroenterol       Date:  2021-12-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.